product summary
company name :
MBL International
product type :
antibody
product name :
anti-IDH1-R132H
catalog :
D299-3
conjugate :
nonconjugated
reactivity :
human
application :
immunohistochemistry
more info or order :
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; human; 1:200
Okamoto S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, et al. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. Brain Tumor Pathol. 2016;33:129-36 pubmed publisher
  • immunohistochemistry; human
Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, et al. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma. J Neurosurg. 2014;121:543-53 pubmed publisher
company information
MBL International
15A Constitution Way Woburn, MA 01801
customerservice@mblintl.com
http://www.mblintl.com
headquarters: United States